Institute of Neurogenomics, Helmholtz Zentrum München, Neuherberg, Germany.
Institute of Human Genetics, Technical University of Munich, Germany.
FEBS Lett. 2021 Apr;595(8):1132-1158. doi: 10.1002/1873-3468.14068. Epub 2021 Mar 21.
Mitochondrial disorders are monogenic disorders characterized by a defect in oxidative phosphorylation and caused by pathogenic variants in one of over 340 different genes. The implementation of whole-exome sequencing has led to a revolution in their diagnosis, duplicated the number of associated disease genes, and significantly increased the diagnosed fraction. However, the genetic etiology of a substantial fraction of patients exhibiting mitochondrial disorders remains unknown, highlighting limitations in variant detection and interpretation, which calls for improved computational and DNA sequencing methods, as well as the addition of OMICS tools. More intriguingly, this also suggests that some pathogenic variants lie outside of the protein-coding genes and that the mechanisms beyond the Mendelian inheritance and the mtDNA are of relevance. This review covers the current status of the genetic basis of mitochondrial diseases, discusses current challenges and perspectives, and explores the contribution of factors beyond the protein-coding regions and monogenic inheritance in the expansion of the genetic spectrum of disease.
线粒体疾病是一类单基因疾病,其特征为氧化磷酸化缺陷,由超过 340 种不同基因中的致病性变异引起。全外显子组测序的实施在其诊断方面带来了一场革命,使相关疾病基因的数量增加了一倍,并显著提高了诊断率。然而,仍有相当一部分表现出线粒体疾病的患者的遗传病因尚不清楚,这凸显了变异检测和解释方面的局限性,这需要改进计算和 DNA 测序方法,以及增加组学工具。更有趣的是,这也表明一些致病性变异位于蛋白质编码基因之外,并且孟德尔遗传和 mtDNA 之外的机制也很重要。本文综述了线粒体疾病遗传基础的现状,讨论了当前的挑战和展望,并探讨了蛋白质编码区和单基因遗传以外的因素在疾病遗传谱扩展中的作用。